Actions
shareshare link cite add Please grant OpenAIRE to access and update your ORCID works.This Research product is the result of merged Research products in OpenAIRE.
You have already added 0 works in your ORCID record related to the merged Research product.
See an issue? Give us feedback
Please grant OpenAIRE to access and update your ORCID works.
This Research product is the result of merged Research products in OpenAIRE.
You have already added 0 works in your ORCID record related to the merged Research product.
You have already added 0 works in your ORCID record related to the merged Research product.
Publication . 2021
Antibody Characterization Report for Peroxiredoxin-6
Ayoubi, Riham; Alshafie, Walaa; Nicouleau, Michael; Durcan, Thomas M.; McPherson, Peter S.; Laflamme, Carl;
Ayoubi, Riham; Alshafie, Walaa; Nicouleau, Michael; Durcan, Thomas M.; McPherson, Peter S.; Laflamme, Carl;
Open Access
English
Published: 30 Apr 2021
Publisher: Zenodo
Abstract
Head to head comparison of available commercial antibodies against Peroxiredoxin-6 by immunoblot (Western blot), immunoprecipitation and immunofluorescence.
Subjects by Vocabulary
Medical Subject Headings: respiratory system
Subjects
Peroxiredoxin-6, PRDX6, P30041, antibody validation, antibody characterization
Peroxiredoxin-6, PRDX6, P30041, antibody validation, antibody characterization
Medical Subject Headings: respiratory system
See an issue? Give us feedback
Beta
SDGsFeedback
Funded by
NIH| Infrastructure to improve reliability of AMP-AD target hypotheses
Project
- Funder: National Institutes of Health (NIH)
- Project Code: 3RF1AG057443-01S2
- Funding stream: NATIONAL INSTITUTE ON AGING
Download from
Do the share buttons not appear? Please make sure, any blocking addon is disabled, and then reload the page.
Head to head comparison of available commercial antibodies against Peroxiredoxin-6 by immunoblot (Western blot), immunoprecipitation and immunofluorescence.